🔗 Permalink

Inventor profile of:

Philippe DENOEL

City:

Rixensart

Country:

Belgium

Published Applications:

Last publication date:

2020-01-02

Top Assignees for applications by Philippe DENOEL

The entities that hold a legal rights for patent applications filed by inventor DENOEL Philippe:

GlaxoSmithKline Biologicals S.A. 23 Rixensart, Belgium
THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION 1 Columbus, OH United States
The Brigham & Women's Hospital, Inc. 1 Boston, MA United States
GlaxoSmithKline 1 King of Prussia, PA United States
GlaxoSmithKline Biologicals SA 1 , Belgium

Recent patent applications by DENOEL Philippe

Philippe DENOEL from Rixensart, BE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-01-02

US20200000911A1

Human necessities

IMMUNOGENIC COMPOSITION

#2 | 2019-10-03

US20190298822A1

Human necessities

Immunogenic composition

#3 | 2018-04-19

US20180104323A1

Human necessities

IMMUNOGENIC COMPOSITION

#4 | 2018-03-08

US20180064806A1

Human necessities

Immunogenic composition

#5 | 2017-10-05

US20170281744A1

Human necessities

METHOD OF TREATMENT

#6 | 2017-03-09

US20170065714A1

Human necessities

Immunogenic composition

#7 | 2017-03-02

US20170056490A1

Human necessities

IMMUNOGENIC COMPOSITION FOR USE IN THERAPY

#8 | 2016-06-23

US20160175423A1

Human necessities

VACCINE COMPOSITION

#9 | 2016-05-12

US20160129101A1

Human necessities

IMMUNOGENIC COMPOSITION FOR USE IN THERAPY

#10 | 2016-03-24

US20160082097A1

Human necessities

NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS

#11 | 2015-02-12

US20150044253A1

Human necessities

Immunogenic composition

#12 | 2014-10-02

US20140294935A1

Human necessities

VACCINE COMPOSITION

#13 | 2014-07-24

US20140205634A1

Human necessities

Treatment of streptococcal infections

#14 | 2014-03-13

US20140072622A1

Human necessities

VACCINE AGAINST STREPTOCOCCUS PNEUMONIAE

#15 | 2013-07-04

US20130171188A1

Human necessities

Immunogenic composition

#16 | 2012-12-27

US20120328659A1

Human necessities

TREATMENT OF STREPTOCOCCAL INFECTIONS

#17 | 2012-07-26

US20120189654A1

Human necessities

VACCINE

#18 | 2012-03-15

US20120064120A1

Human necessities

NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS

#19 | 2012-03-15

US20120064119A1

Human necessities

NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS

#20 | 2012-02-02

US20120027800A1

Human necessities

NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS

#21 | 2011-02-10

US20110033500A1

Human necessities

Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB-neisseria meningitidis

#22 | 2010-12-23

US20100322959A1

Human necessities

Immunogenic composition

#23 | 2010-11-18

US20100291137A1

Human necessities

METHOD FOR REFOLDING NEISSERIAL NSPA PROTEIN

#24 | 2010-01-28

US20100021503A1

Human necessities

IMMUNOGENIC COMPOSITION

#25 | 2009-10-08

US20090252759A1

Human necessities

Immunogenic composition

#26 | 2009-07-09

US20090175912A1

Chemistry; metallurgy

outer membrane protein and use thereof in vaccination

#27 | 2009-06-25

US20090162394A1

Human necessities

VACCINE

#28 | 2009-06-18

US20090155887A1

Chemistry; metallurgy

Vaccine Composition

#29 | 2009-05-28

US20090136541A1

Human necessities

Immunogenic composition

#30 | 2009-05-07

US20090117147A1

Human necessities

VACCINES COMPRISING OUTER MEMBRANE VESICLES FROM GRAM NEGATIVE BACTERIA

#31 | 2009-02-12

US20090041802A1

Human necessities

Immunogenic composition

#32 | 2008-09-25

US20080233154A1

Human necessities

Vaccine Composition

#33 | 2008-08-21

US20080199490A1

Human necessities

Immunogenic composition

#34 | 2008-08-14

US20080193476A1

Human necessities

Immunogenic composition

#35 | 2008-01-31

US20080025993A1

Human necessities

Method for Refolding Neisserial Nspa Protein

#36 | 2007-05-24

US20070116711A1

Human necessities

Pertussis antigens and use thereof in vaccination

#37 | 2006-11-09

US20060251671A1

Chemistry; metallurgy

Haemophilus influenza outer membrane protein and use thereof in vaccination

#38 | 2006-09-28

US20060216307A1

Human necessities

Vaccine composition

#39 | 2006-09-14

US20060204520A1

Chemistry; metallurgy

Vaccine composition

#40 | 2006-06-29

US20060141563A1

Human necessities

Mutant protein and refolding method

#41 | 2006-03-16

US20060057160A1

Human necessities

Vaccine composition

#42 | 2006-03-09

US20060051379A1

Human necessities

Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from LGTB-

#43 | 2006-02-16

US20060034854A1

Human necessities

Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria

InventorID:

323400 ⎘